FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158014750> ?p ?o ?g. }

• W2158014750 endingPage "116" @default.
• W2158014750 startingPage "107" @default.
• W2158014750 abstract "Statin combination therapy and statin uptitration have been shown to be efficacious in low-density lipoprotein cholesterol (LDL-C) lowering and are recommended for patients with high-risk coronary heart disease (CHD) who do not reach guideline-endorsed LDL-C goals on statin monotherapy.This analysis evaluated treatment practice patterns and LDL-C lowering for patients with CHD/CHD risk equivalent on statin monotherapy in a real-world practice setting in the United States.In this retrospective, observational study, patients with CHD/CHD risk equivalent on statin therapy were identified during 2004 to 2008 in a US managed care database. Prescribing patterns and effect of switching from statin monotherapy to combination ezetimibe/simvastatin therapy vs uptitration to higher statin dose/potency level and no change from initial statin potency on LDL-C lowering were assessed. Percentage of change from baseline in LDL-C levels and odds ratios for LDL-C goal attainment were estimated with analyses of covariance and logistic regression.Of 27,919 eligible patients on statin therapy, 2671 (9.6%) switched to ezetimibe/simvastatin therapy, 11,035 (39.5%) uptitrated statins, and 14,213 (50.9%) remained on the same statin monotherapy. LDL-C reduction from baseline and attainment of LDL-C <100 and <70 mg/dL were substantially greater for patients who switched to ezetimibe/simvastatin therapy (-24.0%, 81.2%, and 35.2%, respectively) than for patients who titrated (-9.6%, 68.0%, and 18.4%, respectively) or remained on initial statin therapy (4.9%, 72.2%, and 23.7%, respectively). The odds ratios for attainment of LDL-C <100 and <70 mg/dL were also higher for patients who switched than for patients who uptitrated and had no therapy change than for patients who titrated vs no therapy change. Similarly, among a subgroup of patients not at LDL-C <100 mg/dL on baseline therapy, attainment of LDL-C <100 and <70 mg/dL was greater for patients who switched than for statin uptitration vs no change, as well as for patients who uptritrated statins vs no therapy change.In this study, LDL-C lowering and goal attainment rates improved substantially for patients with high-risk CHD on statin monotherapy who switched to combination ezetimibe/statin or uptitrated their statin therapies; however, approximately one-third of these patients still did not attain the optional recommended LDL-C goal of <70 mg/dL. Moreover, these higher efficacy lipid-lowering therapies were infrequently prescribed, indicating the need for further assessment of barriers to LDL-C goal attainment in actual practice settings." @default.
• W2158014750 created "2016-06-24" @default.
• W2158014750 creator A5001385286 @default.
• W2158014750 creator A5027985963 @default.
• W2158014750 creator A5033223903 @default.
• W2158014750 creator A5036509509 @default.
• W2158014750 creator A5040420889 @default.
• W2158014750 creator A5046066860 @default.
• W2158014750 creator A5054876477 @default.
• W2158014750 creator A5066354341 @default.
• W2158014750 creator A5090460841 @default.
• W2158014750 date "2014-01-01" @default.
• W2158014750 modified "2023-10-07" @default.
• W2158014750 title "Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease" @default.
• W2158014750 cites W1970799753 @default.
• W2158014750 cites W1974768421 @default.
• W2158014750 cites W1977399475 @default.
• W2158014750 cites W1984259359 @default.
• W2158014750 cites W1984387917 @default.
• W2158014750 cites W1991429317 @default.
• W2158014750 cites W2008356419 @default.
• W2158014750 cites W2010505181 @default.
• W2158014750 cites W2025690892 @default.
• W2158014750 cites W2027316231 @default.
• W2158014750 cites W2037413341 @default.
• W2158014750 cites W2043331950 @default.
• W2158014750 cites W2061398329 @default.
• W2158014750 cites W2067142954 @default.
• W2158014750 cites W2067236087 @default.
• W2158014750 cites W2073896718 @default.
• W2158014750 cites W2080998508 @default.
• W2158014750 cites W2082036057 @default.
• W2158014750 cites W2084267118 @default.
• W2158014750 cites W2119355774 @default.
• W2158014750 cites W2123026839 @default.
• W2158014750 cites W2132401646 @default.
• W2158014750 cites W2134120087 @default.
• W2158014750 cites W2136522050 @default.
• W2158014750 cites W2136893214 @default.
• W2158014750 cites W2141773571 @default.
• W2158014750 cites W2142283630 @default.
• W2158014750 cites W2147980803 @default.
• W2158014750 cites W2155784627 @default.
• W2158014750 cites W2161253919 @default.
• W2158014750 cites W2164089346 @default.
• W2158014750 cites W2167045683 @default.
• W2158014750 cites W2167067204 @default.
• W2158014750 cites W2171860082 @default.
• W2158014750 cites W3031812472 @default.
• W2158014750 cites W4240735590 @default.
• W2158014750 doi "https://doi.org/10.1016/j.jacl.2013.09.009" @default.
• W2158014750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24528691" @default.
• W2158014750 hasPublicationYear "2014" @default.
• W2158014750 type Work @default.
• W2158014750 sameAs 2158014750 @default.
• W2158014750 citedByCount "29" @default.
• W2158014750 countsByYear W21580147502014 @default.
• W2158014750 countsByYear W21580147502015 @default.
• W2158014750 countsByYear W21580147502016 @default.
• W2158014750 countsByYear W21580147502017 @default.
• W2158014750 countsByYear W21580147502018 @default.
• W2158014750 countsByYear W21580147502019 @default.
• W2158014750 countsByYear W21580147502020 @default.
• W2158014750 countsByYear W21580147502021 @default.
• W2158014750 countsByYear W21580147502022 @default.
• W2158014750 crossrefType "journal-article" @default.
• W2158014750 hasAuthorship W2158014750A5001385286 @default.
• W2158014750 hasAuthorship W2158014750A5027985963 @default.
• W2158014750 hasAuthorship W2158014750A5033223903 @default.
• W2158014750 hasAuthorship W2158014750A5036509509 @default.
• W2158014750 hasAuthorship W2158014750A5040420889 @default.
• W2158014750 hasAuthorship W2158014750A5046066860 @default.
• W2158014750 hasAuthorship W2158014750A5054876477 @default.
• W2158014750 hasAuthorship W2158014750A5066354341 @default.
• W2158014750 hasAuthorship W2158014750A5090460841 @default.
• W2158014750 hasConcept C126322002 @default.
• W2158014750 hasConcept C142724271 @default.
• W2158014750 hasConcept C164705383 @default.
• W2158014750 hasConcept C2776329913 @default.
• W2158014750 hasConcept C2776839432 @default.
• W2158014750 hasConcept C2776999253 @default.
• W2158014750 hasConcept C2777482532 @default.
• W2158014750 hasConcept C2778657065 @default.
• W2158014750 hasConcept C2780182762 @default.
• W2158014750 hasConcept C71924100 @default.
• W2158014750 hasConceptScore W2158014750C126322002 @default.
• W2158014750 hasConceptScore W2158014750C142724271 @default.
• W2158014750 hasConceptScore W2158014750C164705383 @default.
• W2158014750 hasConceptScore W2158014750C2776329913 @default.
• W2158014750 hasConceptScore W2158014750C2776839432 @default.
• W2158014750 hasConceptScore W2158014750C2776999253 @default.
• W2158014750 hasConceptScore W2158014750C2777482532 @default.
• W2158014750 hasConceptScore W2158014750C2778657065 @default.
• W2158014750 hasConceptScore W2158014750C2780182762 @default.
• W2158014750 hasConceptScore W2158014750C71924100 @default.
• W2158014750 hasIssue "1" @default.
• W2158014750 hasLocation W21580147501 @default.
• W2158014750 hasLocation W21580147502 @default.

• next